Full-Length cDNA, Prokaryotic Expression, and Antimicrobial Activity of UuHb-F-I from<i> Urechis unicinctus</i>

Niu, Rongli; Chen, Xiang

doi:https://doi.org/10.1155/2016/5683026

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results Conclusions Acknowledgments References Copyright Related Articles

Special Issue

Upstream and Downstream of Recombinants Biomolecules to Health Care Industry

View this Special Issue

Research Article | Open Access

Volume 2016 | Article ID 5683026 | https://doi.org/10.1155/2016/5683026

Full-Length cDNA, Prokaryotic Expression, and Antimicrobial Activity of UuHb-F-I from Urechis unicinctus

Rongli Niu¹and Xiang Chen¹

Academic Editor: Jorge G. Farías

Received28 Nov 2015

Revised01 May 2016

Accepted10 May 2016

Published07 Jun 2016

Abstract

Hemoglobin, which widely exists in all vertebrates and in some invertebrates, is possibly a precursor of antimicrobial peptides (AMPs). However, AMPs in the hemoglobin of invertebrates have been rarely investigated. This study is the first to report the full-length cDNA, prokaryotic expression, and antimicrobial activity of UuHb-F-I from Urechis unicinctus. The full-length cDNA sequence of UuHb-F-I was 780 bp with an open-reading frame of 429 bp encoding 142 amino acids. MALDI-TOF-MS suggested that the recombinant protein of UuHb-F-I (rUuHb-F-I) yielded a molecular weight of 15,168.01 Da, and its N-terminal amino acid sequence was MGLTGAQIDAIK. rUuHb-F-I exhibited different antimicrobial activities against microorganisms. The lowest minimum inhibitory concentration against Micrococcus luteus was 2.78–4.63 M. Our results may help elucidate the immune defense mechanism of U. unicinctus and may provide insights into new AMPs in drug discovery.

1. Introduction

Hemoglobin (Hb), which widely exists in all vertebrates and in some invertebrates, contains endogenous biologically active proteins [1] exhibiting various properties, including hormone release and immunomodulatory, hematopoietic, coronaroconstrictory, antigonadotropic, and opioid-like activities [2]. Hb is also a possible precursor of antimicrobial peptides (AMPs) [3–10]. Thus far, 30 AMPs have been derived from peptic Hb hydrolysates, 24 peptides have been obtained from the α chain of Hb, and 6 peptides have been obtained from the β chain of Hb [10, 11]. Intact Hbα or Hbβ is also a potent antibacterial protein [5]. Hence, Hb-associated AMPs have been extensively investigated. However, few Hb-associated AMPs in invertebrates have been reported [12].

Urechis unicinctus (Uu), a marine spoon worm, is economically important seafood mainly distributed throughout Russia, Japan, Korea, and China. Uu possesses a well-developed body cavity filled with coelomic fluid, which contains cells with Hb. In general, AMPs are found in most living organisms and considered an essential component of an organism’s innate immune system [13]. Thus, AMPs may be found in the Hb or coelomic fluid of Uu. AMPs may also play an important role in its innate immune system. However, the Hb of Uu and its antimicrobial activity have yet to be described. Novel AMPs or antimicrobial substances from the blood of Uu should be identified and isolated. In this study, the Hb of Uu was analyzed and its cDNA was cloned. Recombinant expression and antimicrobial activity assay were then performed. Our research on the structure and potential function of Hb may help elucidate the immune defense mechanism of invertebrates. This study may also provide insights into new AMPs for drug discovery and disease control in U. unicinctus aquaculture.

2. Materials and Methods

2.1. Cloning of the cDNA of UuHb-F-I Fragment

The coelomic fluid of an adult fresh Uu (about 20.5 cm in length and 30.5 g in mass) was collected and centrifuged at 12,000 rpm for 5 min at 4°C. The precipitates were collected and RNA was extracted by using a Trizol kit in accordance with the manufacturer’s protocol (Shenggong Bioengineering Co., Ltd., China). First-strand cDNA was synthesized with M-MLV reverse transcriptase, oligo dT, dNTP mix, and total RNA. Then, PCR was conducted in 20 L reaction mixture containing 1 L of first-strand cDNA, 0.5 L of each primer (primers P1 and P2; Table 1), 10 L of 2x Taq Master Mix (Omega Bio-Tek), and 8 L of MilliQ H₂O. Amplifications were performed on PCR 3 Block Professional Thermocycler (Biometra) under the following conditions: initial denaturation at 94°C for 3 min, 30 cycles of denaturation at 94°C for 30 s, annealing at 48°C for 30 s, extension at 72°C for 50 s, and final extension at 72°C for 10 min. The obtained cDNA was further purified with a SanPrep PCR product purification kit (Shenggong Bioengineering Co., Ltd., China) and cloned into pUM-T vector. Positive recombinants were transformed into competent DH5α cells, identified through anti-Amp selection, and verified through double digestion with Sal I and BamH I (Thermo Scientific). Afterward, the positive clone was sequenced (Nanjin Jinsirui Biotechnology Ltd., Co., China).

2.2. Full-Length cDNA Sequence Determination

2.2.1. 3′-RACE

3′-RACE was performed using 3′-Full RACE Core Set with PrimeScript RTase (TaKaRa) in accordance with manufacturer’s instructions. Nested PCR was conducted in 3′-RACE outer primer and 3′-RACE-GSP1 or 3′-RACE inner primer and 3′-RACE-GSP2 (Table 1). The first round of PCR was performed using a reaction mixture containing 1 L of the first-strand cDNA, 0.5 L of each primer (10 M), 2 L of 10x Trans Taq HiFi buffer, 2 L of dNTPs (2.5 mM), 0.3 L of Trans Taq HiFi DNA Polymerase (TransGen Biotech), and 13.7 L of MilliQ H₂O. The second round of PCR was conducted using a reaction mixture with 2 L of outer PCR purified product, 1 L of each primer (10 M), 5 L of 10x Trans Taq HiFi buffer, 4 L of dNTPs (2.5 mM), 0.5 L of Trans Taq HiFi DNA polymerase, and 36.5 L of MiliQ H₂O. The amplifications of the first round were performed with initial denaturation at 94°C for 3 min, 30 cycles with denaturation at 94°C for 30 s, annealing at 48°C for 30 s, extension at 72°C for 50 s, and the final extension step at 72°C for 10 min. The second round was performed in the same manner as that of the first round except annealing at 56°C. The inner PCR product was ligated with pUM-T vector and further purified and transformed into DH5α. The detailing process was the same as above. The sequence was then determined (Nanjin Jinruisi Biotechnology Ltd., Co., China).

2.2.2. 5′-RACE

5′-RACE was performed using 5′-Full RACE kit with TAP (TaKaRa) in accordance with the manufacturer’s instructions. Nested PCR was conducted with 5′-RACE outer primer and 5′-RACE-GSP1 or 5′-RACE inner primer and 5′-RACE-GSP2. The PCR system in the first round contained 2 L of reverse transcriptase, 1 L of each primer, 5 L of 10x Trans Taq HiFi buffer, 4 L of dNTP (2.5 mM), 0.5 L of Trans Taq HiFi DNA polymerase, and 36.5 L of MilliQ H₂O. The touchdown PCR profile was as follows: initial denaturation at 94°C for 3 min; 30 cycles at 94°C for 30 s, at 60°C for 30 s (decreased by 0.5°C in each cycle), and at 72°C for 1 min; 10 cycles at 94°C for 30 s, at 45°C for 30 s, and at 72°C for 1 min; final extension at 72°C for 10 min; and being terminated at 15°C. The inner PCR was performed using 1 L of the purified outer PCR product, 1 L of each primer, 5 L of 10x Trans Taq HiFi buffer, 4 L of dNTPs (2.5 mM), 0.5 L of Trans Taq HiFi DNA polymerase, and 37.5 L of MilliQ H₂O. The touchdown PCR was performed using the following parameters: 94°C for 3 min; 30 cycles at 94°C for 30 s, at 66°C for 30 s (decreased by 0.5°C in each cycle), and at 72°C for 40 s; 10 cycles at 94°C for 30 s, at 51°C for 30 s, and at 72°C for 40 s; final extension at 72°C for 10 min; and being terminated at 15°C. After the results were verified through electrophoresis, the product was sequenced to obtain the full length of UuHb-F-I cDNA.

2.3. Bioinformatics Analysis

Bioinformatics was conducted to predict the new gene and the conservation, consistency, and structure of the mature peptide. The homology of nucleotide and protein sequences was blasted by using an online tool at the National Center for Biotechnology Information (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The deduced amino acid sequence was analyzed by using a translate tool (http://web.expasy.org/translate/). Clustal X and DNAman were used to perform multiple alignments of amino acid sequences. The presence and location of a signal peptide were predicted by using SignalP 4.1 Server online. ProtScale (Hphob/Kyte & Doolittle), Sopma, and Phyre2 online software were adopted to analyze possible amphiphytes and structures.

2.4. Expression and Purification of Recombinant UuHb-F-I

2.4.1. Construction of Recombinant UuHb-F-I

The CDS sequence, encoding mature peptide of UuHb-F-I, was amplified by a pair of primers (CDS-P1 and CDS-P2). The PCR product and pET-22b⁺ plasmids were double-digested with Nde I and Xho I (Thermo Scientific). Afterward, the purified product was inserted into pET-22b⁺ vector by the T4 ligation enzyme. The ligation product was transformed into competent BL21(DE3) cells and sequenced to ensure in-frame insertion. Blank pET-22b⁺ plasmids were used as a negative control.

2.4.2. Expression and Determination of Recombinant Protein

BL21(DE3)/pET-22b⁺ and BL21(DE3)/pET22b-UuHb-F-I were inoculated in a TB medium with Amp (100 g/mL) at 200 rpm and 37°C until OD₆₀₀ of 0.6–0.8 was reached. Isopropyl--D-thiogalactosidase (IPTG, 100 mM) was added to induce expression under the same conditions. The cells were harvested through centrifugation at 12,000 rpm for 1 min. Inducing conditions, including the final IPTG concentration and induction time, were optimized.

Lactose instead of IPTG was used to induce protein expression. The positive transformants of UuHb-F-I and the negative control were incubated in an FML medium composed of 15 g/L tryptone, 12 g/L yeast extract, 3 g/L NaH₂PO₄2H₂O, 7 g/L K₂HPO₄3H₂O, 2.5 g/L NaCl, 0.2% glucose, 2.1 mM lactose, 0.05% MgSO₄7H₂O, and 100 g/mL Amp at 37°C with shaking at 180 rpm in accordance with the procedure involving IPTG. Lactose was added to induce expression; the cells were then harvested. The induction time obtained using lactose was compared with that recorded using IPTG. The quantities of the expressed proteins were compared through SDS-PAGE.

The recombinant protein of UuHb-F-I (rUuHb-F-I) was further confirmed through Western blot analysis. After SDS-PAGE was conducted, the proteins were transferred from the gel to a PVDF film. The film was blocked with 5% fat-free milk, inoculated with His-Tag (27E8) mouse mAb (Cell Signaling) and peroxidase-conjugated AffiniPure goat anti-mouse IgG (H+L) (Shenggong Bioengineering Co., Ltd., China), and colored with a stable peroxide solution (A) and a luminol/enhancer solution (B). Images were captured using ChemiDoc MP imaging system (Bio-Rad).

2.4.3. Purity and Renaturation of Recombinant Proteins

Lactose was used to induce protein expression. The recombinant strain of pET-22b-UuHb-F-I was inoculated in an LB medium, transferred to 100 mL of FML in a 1 L flask, and cultivated for 16 h at 37°C with 180 rpm. The cultivation solution was centrifuged at 10,000 rpm for 10 min. The pellet was solubilized with cell lysates (0.5 M NaCl, 50 mM Tris-HCl, 1 mM EDTA, and 0.5% Triton X-100, pH 7.4). The solution was sonicated for 20 min with 2 s ultrasonication and 2 s intervals at 400 W power and centrifuged at 10,000 rpm and 4°C for 20 min. The pellet contained inclusion bodies, which were further washed with buffer I (0.5 M NaCl, 50 mM Tris-HCl, 2 M urea, 0.5% Triton X-100, and 1 mM EDTA, pH 7.4) and dissolved in buffer II (0.5 M NaCl, 50 mM Tris-HCl, 8 M urea, and 1 mM EDTA, pH 7.4). The supernatant was prepared for column purification. The samples from each step subjected to SDS-PAGE to determine the target protein. rUuHb-F-I was purified with Ni⁺ affinity resins under denaturation conditions.

The purified proteins were renatured through dialysis in the following: gradient urea glycerol buffer (0.5 M NaCl, 50 mM Tris-HCl, 1% glycine, 10% glycerol, 1 mM EDTA, and a gradient concentration of 4, 2, and 1 M urea in each gradient, pH 7.4; each gradient for 4 h); PBS for 4 h; and deionized water for 8 h. The sample was cold-dried and analyzed through SDS-PAGE.

2.5. Determination of the Molecular Weight and Amino Sequence of the Purified rUuHb-F-I

The molecular weight of the purified rUuHb-F-I was confirmed by using an ABI 5800 MALDI-TOF/TOF plus mass spectrometer (AB SCIEX) operated in a linear mode at Boyuan Bio-Tech Co. (Shanghai, China). MS and MS/MS data were integrated and analyzed in GPS Explorer V3.6 (Applied Biosystems, USA) with default parameters. The MS/MS spectra revealed that proteins were successfully obtained, as indicated by ≥95% confidence interval of their scores in MASCOT V2.3 search engine (Matrix Science Ltd., London, UK).

2.6. Antimicrobial Analysis

The lyophilized protein was dissolved in acetic acid (0.025%, V/V) at different concentrations: 1, 1.67, 2.78, 4.63, 7.72, 12.86, 21.4, 35.7, 59.5, and 99.2 M. The concentration of rUuHb-F-I was estimated by using a BCA protein kit (Thermo Scientific). The antimicrobial activities of eight microbial strains were measured: three Gram-positive bacteria, namely, Staphylococcus aureus, Bacillus subtilis, and Micrococcus luteus; four Gram-negative bacteria, namely, Escherichia coli (ATCC8739), Pseudomonas aeruginosa, Vibrio alginolyticus, and Vibrio parahaemolyticus; and one fungus, namely, Pichia pastoris GS115 (China General Microbiological Culture Collection Center (CGMCC, China)). V. alginolyticus and P. pastoris GS115 were cultured in TSB (17 g/L tryptone, 3 g/L soytone, 5 g/L NaCl, 2.5 g/L glucose, and 2.5 g/L K₂HPO₄) and YPD (2% (W/V) tryptone, 2% (W/V) D-glucose, and 1% (W/V) yeast extract) at 30°C, separately. Other bacteria were cultured in TSB at 37°C. Antibacterial activity was analyzed through a liquid phase assay, as described previously [14, 15]. The strains were initially adjusted to 10³ CFU/mL with LTM (1% agar in PBS); afterward, 120 L of each strain was seeded into 96-well plate, and each well contained 50 L of the protein sample. The plate was incubated for 3 h at 37°C or 30°C. Subsequently, 125 L of the medium was added to each well and cultivated for another 12 h. Then, 100 L sample from each well was spread onto plates and cultivated for 24 h. The highest growth concentration and the lowest inhibitory concentration were recorded. Minimum inhibitory concentration (MIC) was determined by using the following equation: , where is the highest protein concentration of bacterial growth and is the lowest protein concentration that totally inhibited bacterial growth. Acetic acid (0.025%) was used as a negative control. Isopropanol (70%) was used as a positive control for P. pastoris GS115. Chloramphenicol solution (0.68 mg/mL) was utilized as a positive control for other bacteria. Each treatment was repeated thrice.

3. Results

3.1. cDNA Cloning and Sequence Analysis of UuHb-F-I

On the basis of Urechis caupo F-I complete CDS (GI:945055), we obtained the cDNA of U. unicinctus. The nucleotide and deduced amino acid sequences are shown in Figure 1, and the sequence data were deposited in GenBank (KJ865621).

Figure 1

Nucleotide and deduced amino acid sequences of F-I chain of hemoglobin from Urechis unicinctus. The start codon (ATG) is boxed. The stop codon (TAA) is indicated by an asterisk. The polyadenylation signal motif (AATAAA) is in dotted line. The protein sequence of UuHb-F-I deduced from the nucleotide sequence is underlined. The letters underlined with a curve line are the predicted combining site of heme to protein. The poly(A) is double-underlined. Numbers on the right side of the sequence show the positions of the last nucleotide or amino acid on each line.

The full-length cDNA sequence of UuHb-F-I was 780 bp. It contains 95 bp 5′-untranslated region (UTR), 256 bp 3′-UTR, and 429 bp open-reading frame (ORF) encoding 142 amino acids (AA). The poly(A) tail was found in UuHb-F-I, and a canonical polyadenylation signal sequence (AATAAA) was detected. The estimated molecular weight of mature UuHb-F-I was 15,120.67 Da, and the theoretical isoelectric point was 9.02. Moreover, numerous α-helices were observed in the secondary structure of mature UuHb-F-I. UuHb-F-I is amphiphilic, as analyzed by Hphob./Kyte & Doolittle in ProtScale. Signal peptide prediction revealed no signal sequences in UuHb-F-I. Using Sopma and Phyre2, we could further predict the secondary and tertiary structures of this protein (not shown in this study).

BLAST analysis revealed that the nucleotide acid and deduced amino acid sequences of UuHb-F-I matched those of UcHb-F-I, with 82%–87% and 79% similarities, respectively [16]. By contrast, the sequence similarities to other organisms were relatively low and mainly conserved in the binding site (Figure 2). UuHb-F-I displayed 43%, 36%, and 13.79% amino acid identities with Capitella teleta (GI:443723524), Daphnia magna (GI:322229317) [17], and human hemoglobin chain (GI:3114508), respectively.

Figure 2

Multiple alignment of amino acid sequences of UuHb-F-I with other known globins. Amino acid residues that are conserved in the same sequences are shaded in black; similar amino acids of at least 60% are shaded in gray. Numbers on the right indicate the amino acid position of the different sequences. The heme-binding domains are marked with asterisk above the alignment. The species and the GenBank accession numbers are as follows: UuHb-F-I (Urechis unicinctus hemoglobin F-I), UcHb-F-I (Urechis caupo hemoglobin F-I, GI:122733), and Ct-Hp (Capitella teleta hypothetical protein, GI:443723524).

3.2. Expression and Purification of Recombinant UuHb-F-I

The recombinant plasmids pET-22b-UuHb-F-I were transformed and expressed in E. coli BL21(DE3) (Tianjin, China). The results showed that the protein expression level of the inducing group was much higher than that of the noninducing group. The blank plasmid did not induce band expression; this finding suggested that BL21(DE3)/pET22b-UuHb-F-I was the actual strain that induced expression. We further optimized the IPTG inducing conditions and observed that the highest protein expression level was obtained at 1 mM IPTG and 3 h induction time. We also induced the protein expression by using lactose and found that the highest protein expression level was determined at 16 h induction time. The obtained protein expression level at 16 h was higher than that recorded at 8 or 12 h.

After induction was completed, the whole cell lysate and insoluble fraction were analyzed through SDS-PAGE. The results revealed that the recombinant UuHb-F-I was mainly expressed as insoluble proteins and accumulated in inclusion bodies. Western blot (Figure 3) demonstrated that the recombinant strain could produce recombinant proteins with His-Tag after induction was completed. This finding confirmed that the obtained protein was indeed the target protein. The target protein was purified using Ni⁺ affinity column (Figure 4), dialyzed, and cold-dried for antibacterial assay. The purified rUuHb-F-I was further measured by MALDI-TOF-MS/MS. The result showed that the pure peptide yielded an observed molecular mass of 15168.01 Da, and its N-terminal sequence was MGLTGAQIDAIK.

3.3. Antimicrobial Activities of rUuHb-F-I

The antibacterial activities of rUuHb-F-I are described in Table 2. rUuHb-F-I exhibited inhibitory activity against G⁺ and G⁻. Among the obtained MICs, the MIC against M. luteus was the smallest, with 2.78–4.63 M. The MIC against S. aureus was 7.72–12.86 M. The MIC of rUuHb-F-I against G⁻, such as E. coli and P. aeruginosa, was 35.7–59.5 M, which was higher than that of G⁺. This protein also elicited an inhibitory effect on V. parahaemolyticus, with MIC of 21.4–35.7 M. By contrast, this protein did not affect V. alginolyticus and P. pastoris GS115.

4. Discussions

This study is the first to report the full-length cDNA, prokaryotic expression, and antimicrobial activity of UuHb-F-I from U. unicinctus.

Sequence analysis revealed that the mature peptide of UuHb-F-I is a globin belonging to the heme protein family. UuHb-F-I contains many α-helices (70.42%) and heme-binding sites. These properties are similar to those of Hb in other animals [14, 16]. The nucleotide acid and deduced amino acid sequences of UuHb-F-I exhibited 82%–87% and 79% similarities to those of UcHb-F-I, respectively. The combination sites of heme with UuHb-F-I are 31 (F), 41 (D), 44 (F), 45 (F), 65 (Q), 68 (T), 94 (S), 95 (H), 105 (F), and 108 (L), which are consistent with those of UcHb-F-I. UcHb-F-I contains 137 (L) sites, but UuHb-F-I does not consist of these sites. Therefore, Uu and Uc were derived from the same descendent, and their Hb-F-I was the same.

The mechanism of AMPs shows that positive charges and amphiphilic α-helices are common molecular structures which accounted for their antimicrobial activity [18, 19]. Zhu et al. [15] reported that α-helices in peptides and charges are responsible for antimicrobial activities; changes in amphiphilicity can affect antimicrobial properties. Giangaspero et al. [20] suggested that antimicrobial activities may be decreased by reducing the positive charges or the number of α-helices. Our results showed that UuHb-F-I contains many α-helices (70.42%). Therefore, UuHb-F-I could exhibit antimicrobial activity. Uu with a unique Hb can live in active pathogenic zones, such as muds and burrows in sand, because of this property and thus protect themselves from other microbial invasions.

As a strong inducer, IPTG can induce high protein productivity at low doses. In this study, the expression level increased as IPTG concentration increased within a certain range, and the maximum product was obtained at 1 mM IPTG after 3 h of induction. However, IPTG might be replaced with lactose because of its high costs and toxicity. Lactose can produce the same or greater expression level than that of IPTG [21–23]. Our result indicated that lactose could induce the expression of relatively pure proteins and thus simplify purification. rUuHb-F-I was purified and further quantified through MALDI-TOF-MS/MS. The result revealed that the pure peptide yielded an observed molecular mass of 15,168.01 Da, and its N-terminal sequence was MGLTGAQIDAIK. The other amino sequence fragments exhibited a theoretical molecular mass of 15,120.67 Da, and this finding is consistent with that of amino acid sequences subjected to blast analysis. Therefore, rUuHb-F-I is the same as UuHb-F-I. With AMP prediction (CAMPR3 Collection of Anti-Microbial Peptides, http://www.camp.bicnirrh.res.in/predict_c/hii.php), many fragments in UuHb-F-I are predicted as AMPs by the Support Vector Machine classifier. For example, GLTGAQIDAIKGHWFTNIKG in positions 2–21 exhibits AMP probabilities of 1.0 (nucleotide acid sequence) and 0.873 (peptide sequence). Nevertheless, the hydrolysis of rUuHb-F-I should be further investigated.

In the current research, G⁺, G⁻, and fungus, especially common pathogenic species in aquaculture, such as V. alginolyticus and V. parahaemolyticus, may help elucidate the innate immunity of Uu. Bao et al. [12] indicated that Tg-HbI (Hb dimer) from Tegillarca granosa is involved in immune defense responses against microbial infection because the mRNA expression of Tg-HbI (Hb dimer) is significantly upregulated after T. granosa is subjected to V. parahaemolyticus challenge. Thus, our future work will conduct bacterial challenge to investigate the relationship between Hb and defense mechanisms of Uu.

In general, Hb and its fraction exhibit different antimicrobial activities against microorganisms through recombination or isolation [5]. Zhang et al. [11] reported that AJHb, derived from Hb-α in Japanese eel, exhibits a strong antibacterial activity against Edwardsiella tarda, with an MIC of 11.30 μM of MIC. Srihongthong et al. [24] found that the Hb of alligator Hb exerts biological activity against G⁺Bacillus species, such as B. amyloliquefaciens, B. subtilis, and B. pumilus. Belmonte et al. [25] showed that the MICs of Hb98-114 against Cryptococcus neoformans and Candida tropicalis are 1.6 and 2.1 μM, respectively. Consistent with previous findings, our results revealed that rUuHb-F-I exhibits a wide range of inhibitory activities and broad antibacterial spectrum against G⁺ and G⁻ bacteria from nonaquatic and aquatic pathogenic species. Our results also showed that the inhibitory effects of rUuHb-F-I were stronger against G⁺ than against G⁻. By comparison, rUuHb-F-I did not affect P. pastoris GS115. The lowest MIC was 2.78–4.63 M observed in M. luteus. Therefore, rUuHb-F-I is an antibacterial protein or AMP precursor, which may exhibit functional diversities or selective antimicrobial activities. The results also suggested that U. unicinctus, similar to other aquaculture animals, may possess an innate peptide-dependent host defense system to eradicate microbes, as indicated by an MIC of 21.4–35.7 M against V. parahaemolyticus. Thus, our study provided a basis for the development of potent therapeutics or agents against U. unicinctus disease. Further studies on the digestion of rUuHb-F-I or its effects on other pathogens should be performed to produce highly active AMPs.

5. Conclusions

This study is the first to report the full-length cDNA, prokaryotic expression, and antimicrobial activity of UuHb-F-I from U. unicinctus. The full-length cDNA sequence was 780 bp with an ORF of 429 bp encoding 142 AA. The amino acid sequence of the N-terminal chain of rUuHb-F-I was MGLTGAQIDAIK with a molecular mass of 15,168.01 Da. This protein exhibited stronger inhibitory effects against G⁺ than against G⁻. By comparison, this protein did not affect P. pastoris GS115. The lowest MIC observed in M. luteus was 2.78–4.63 M.

Competing Interests

The authors declare that they have no competing interests.

Acknowledgments

This work was supported by the Fujian Province Overseas Studies Program and Natural Science Foundation of Fujian Province (Grant no. 2014J01365).

References

V. T. Ivanov, A. A. Karelin, M. M. Philippova, I. V. Nazimov, and V. Z. Pletnev, “Hemoglobin as a source of endogenous bioactive peptides: the concept of tissue-specific peptide pool,” Biopolymers—Peptide Science Section, vol. 43, no. 2, pp. 171–188, 1997.
View at: Google Scholar
P. Mak, K. Wójcik, J. Silberring, and A. Dubin, “Antimicrobial peptides derived from heme-containing proteins: hemocidins,” Antonie van Leeuwenhoek, vol. 77, no. 3, pp. 197–207, 2000.
View at: Publisher Site | Google Scholar
D. Hobson and J. G. Hirsh, “The antibacterial activity of hemoglobin,” Journal of Experimental Medicine, vol. 107, no. 2, pp. 167–183, 1958.
View at: Publisher Site | Google Scholar
A. C. Fogaça, P. I. da Silva Jr., M. T. M. Miranda et al., “Antimicrobial activity of a bovine hemoglobin fragment in the tick Boophilus microplus,” The Journal of Biological Chemistry, vol. 274, no. 36, pp. 25330–25334, 1999.
View at: Publisher Site | Google Scholar
C. A. Parish, H. Jiang, Y. Tokiwa et al., “Broad-spectrum antimicrobial activity of hemoglobin,” Bioorganic & Medicinal Chemistry, vol. 9, no. 2, pp. 377–382, 2001.
View at: Publisher Site | Google Scholar
C. Liepke, S. Baxmann, C. Heine, N. Breithaupt, L. Ständker, and W.-G. Forssmann, “Human hemoglobin-derived peptides exhibit antimicrobial activity: a class of host defense peptides,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 791, no. 1-2, pp. 345–356, 2003.
View at: Publisher Site | Google Scholar
P. Mak, K. Wójcik, Ł. Wicherek, P. Suder, and A. Dubin, “Antibacterial hemoglobin peptides in human menstrual blood,” Peptides, vol. 25, no. 11, pp. 1839–1847, 2004.
View at: Publisher Site | Google Scholar
J. M. O. Fernandes and V. J. Smith, “Partial purification of antibacterial proteinaceous factors from erythrocytes of Oncorhynchus mykiss,” Fish & Shellfish Immunology, vol. 16, no. 1, pp. 1–9, 2004.
View at: Publisher Site | Google Scholar
N. Nedjar-Arroume, V. Dubois-Delval, K. Miloudi et al., “Isolation and characterization of four antibacterial peptides from bovine hemoglobin,” Peptides, vol. 27, no. 9, pp. 2082–2089, 2006.
View at: Publisher Site | Google Scholar
N. Nedjar-Arroume, V. Dubois-Delval, E. Y. Adje et al., “Bovine hemoglobin: an attractive source of antibacterial peptides,” Peptides, vol. 29, no. 6, pp. 969–977, 2008.
View at: Publisher Site | Google Scholar
D. L. Zhang, R. Z. Guan, W. S. Huang, and J. Xiong, “Isolation and characterization of a novel antibacterial peptide derived from hemoglobin alpha in the liver of Japanese eel, Anguilla japonica,” Fish and Shellfish Immunology, vol. 35, no. 3, pp. 625–631, 2013.
View at: Publisher Site | Google Scholar
Y. B. Bao, Q. Wang, and Z. Lin, “Hemoglobin of the bloody clam Tegillarca granosa (Tg-HbI) is involved in the immune response against bacterial infection,” Fish & Shellfish Immunology, vol. 31, no. 4, pp. 517–523, 2011.
View at: Publisher Site | Google Scholar
P. H. Mygind, R. L. Fischer, K. M. Schnorr et al., “Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus,” Nature, vol. 437, no. 7061, pp. 975–980, 2005.
View at: Publisher Site | Google Scholar
T. Hasegawa, F. Shishikura, and T. Kuwada, “Side-necked turtle (Pleurodira, Chelonia, reptilia) hemoglobin: cDNA-derived primary structures and X-ray crystal structures of Hb A,” IUBMB Life, vol. 63, no. 3, pp. 188–196, 2011.
View at: Publisher Site | Google Scholar
X. Zhu, N. Dong, Z. Wang et al., “Design of imperfectly amphipathic α-helical antimicrobial peptides with enhanced cell selectivity,” Acta Biomaterialia, vol. 10, no. 1, pp. 244–257, 2014.
View at: Publisher Site | Google Scholar
J. R. Garey and A. F. Riggs, “The hemoglobin of Urechis caupo. The cDNA-derived amino acid sequence,” The Journal of Biological Chemistry, vol. 261, no. 35, pp. 16446–16450, 1986.
View at: Google Scholar
O. Simakov, F. Marletaz, S.-J. Cho et al., “Insights into bilaterian evolution from three spiralian genomes,” Nature, vol. 493, no. 7433, pp. 526–531, 2013.
View at: Publisher Site | Google Scholar
Q. Y. Zhao, J. M. Piot, V. Gautier, and G. Cottenceau, “Isolation and characterization of a bacterial growth-stimulating peptide from a peptic bovine hemoglobin hydrolysate,” Applied Microbiology and Biotechnology, vol. 45, no. 6, pp. 778–784, 1996.
View at: Publisher Site | Google Scholar
Y. Shai, “Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides,” Biochimica et Biophysica Acta—Biomembranes, vol. 1462, no. 1-2, pp. 55–70, 1999.
View at: Publisher Site | Google Scholar
A. Giangaspero, L. Sandri, and A. Tossi, “Amphipathic α helical antimicrobial peptides,” European Journal of Biochemistry, vol. 268, no. 21, pp. 5589–5600, 2001.
View at: Publisher Site | Google Scholar
D. Woyski and J. R. Cupp-Vickery, “Enhanced expression of cytochrome P450s from lac-based plasmids using lactose as the inducer,” Archives of Biochemistry and Biophysics, vol. 388, no. 2, pp. 276–280, 2001.
View at: Publisher Site | Google Scholar
B. V. Kilikian, I. D. Suárez, C. W. Liria, and A. K. Gombert, “Process strategies to improve heterologous protein production in Escherichia coli under lactose or IPTG induction,” Process Biochemistry, vol. 35, no. 9, pp. 1019–1025, 2000.
View at: Publisher Site | Google Scholar
E. Dekel and U. Alon, “Optimality and evolutionary tuning of the expression level of a protein,” Nature, vol. 436, no. 7050, pp. 588–592, 2005.
View at: Publisher Site | Google Scholar
S. Srihongthong, A. Pakdeesuwan, S. Daduang, T. Araki, A. Dhiravisit, and S. Thammasirirak, “Complete amino acid sequence of globin chains and biological activity of fragmented crocodile hemoglobin (Crocodylus siamensis),” The Protein Journal, vol. 31, no. 6, pp. 466–476, 2012.
View at: Publisher Site | Google Scholar
R. Belmonte, C. E. Cruz, J. R. Pires, and S. Daffre, “Purification and characterization of Hb 98-114: a novel hemoglobin-derived antimicrobial peptide from the midgut of Rhipicephalus (Boophilus) microplus,” Peptides, vol. 37, no. 1, pp. 120–127, 2012.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2016 Rongli Niu and Xiang Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1976

Downloads

986

Citations